1–4 of 4 results for trial results
Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Toxicity: RELIEF Trial Results
Karen M Wai, MD
STEPHEN J SMITH, MD
Updates from the Field
2025
Episode 176: Journal Club with Drs. Ferhina and M. Ali Khan discussing Preoperative Anti-VEGF, RD after Intravitreal Injection, and Influence of CATT Trial Results
Jayanth Sridhar, MD
Member Podcasts
2019
Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial
Nancy M. Holekamp, MD, FASRS
2016
Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema
Thomas A. Ciulla, MD, MBA, FASRS
2017